These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prediction of drug metabolism and interactions on the basis of in vitro investigations. Pelkonen O; Turpeinen M; Uusitalo J; Rautio A; Raunio H Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):167-75. PubMed ID: 15733211 [TBL] [Abstract][Full Text] [Related]
23. [Influence of disease on the metabolism and effects of drugs in man]. Lavigne JG Union Med Can; 1980 Dec; 109(12):1718-22. PubMed ID: 7210314 [No Abstract] [Full Text] [Related]
24. [Study of hepatic drug metabolism. For a rationalization of a new molecular development]. Le Dinh T; Christoforov B Therapie; 1994; 49(2):133-40. PubMed ID: 7817337 [TBL] [Abstract][Full Text] [Related]
25. [Metabolism and toxicity of drugs used during pregnancy and perinatal period]. Prandota J; Iwańczak F Pediatr Pol; 1980 Apr; 55(4):517-24. PubMed ID: 6997824 [No Abstract] [Full Text] [Related]
26. Drug-binding cavities in long-lived biologics: cause for concern but also potential benefit. Panayotatos N J Clin Pharmacol; 2008 Oct; 48(10):1208-11. PubMed ID: 18812610 [TBL] [Abstract][Full Text] [Related]
28. Clinical usefulness of tests of hepatic drug metabolism. Bircher J Agressologie; 1982 Jan; 23(A):31-4. PubMed ID: 7081581 [No Abstract] [Full Text] [Related]
29. Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics. Oliveira EJ; Watson DG Biomed Chromatogr; 2000 Oct; 14(6):351-72. PubMed ID: 11002274 [TBL] [Abstract][Full Text] [Related]
31. Biotransformation of drugs in human skin. Svensson CK Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027 [TBL] [Abstract][Full Text] [Related]
32. [Clinical aspects of the fate of drugs in the body]. Lazowski J; Rewerski W Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1595-600. PubMed ID: 6679083 [No Abstract] [Full Text] [Related]
33. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Baillie TA Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111 [TBL] [Abstract][Full Text] [Related]
34. Clinical implications of genetic polymorphism in drug metabolism. Tucker GT J Pharm Pharmacol; 1994 May; 46 Suppl 1():417-24. PubMed ID: 8064560 [No Abstract] [Full Text] [Related]
35. [Species differences in the metabolism of drugs]. Sjöqvist F Nord Med; 1967 Oct; 78(42):1364. PubMed ID: 5590749 [No Abstract] [Full Text] [Related]
36. [Interactions by diltiazem (4). Relationship between first pass metabolism of various drugs and absorption enhancement by diltiazem]. Etoh A; Kohno K Yakugaku Zasshi; 1983 May; 103(5):581-8. PubMed ID: 6644549 [No Abstract] [Full Text] [Related]
37. [The significance of the enterohepatic circulation in the metabolism of hormones and drugs]. Bakke OM Nord Med; 1970 Oct; 84(41):1289-95. PubMed ID: 5469319 [No Abstract] [Full Text] [Related]
38. [The binding of drugs with erythrocytes]. Gneushev ET; Gneusheva IA Eksp Klin Farmakol; 1996; 59(5):71-5. PubMed ID: 9026220 [TBL] [Abstract][Full Text] [Related]
39. [Clinical pharmacology for midwives. 2. Pregnancy and drugs. (2). Maternal-fetal exchange]. Yanaginuma T Josanpu Zasshi; 1984 May; 38(5):430-6. PubMed ID: 6564208 [No Abstract] [Full Text] [Related]
40. [Changes in pharmacokinetics in the aged and their practical consequences]. Höffler D Z Gerontol; 1981; 14(5):382-7. PubMed ID: 7303810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]